Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.

Agreement of three commercial anti-extractable nuclear antigen tests: EUROASSAY Anti-ENA Profile, Polycheck Autoimmune Test and FIDIS Connective Profile

Article information

Kosin Med J. 2018;33(3):307-317
Publication date (electronic) : 2018 January 19
doi : https://doi.org/10.7180/kmj.2018.33.3.307
Namhee Kim1,2, In-Suk Kim,1,2, Chulhun L Chang1,2, Hyung-Hoi Kim1,3, Eun Yup Lee1,3
1Department of Laboratory Medicine, School of Medicine, Pusan National University, Busan, Korea
2Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
3Department of Laboratory Medicine, Pusan National University Hospital, Busan, Korea
Corresponding Author: In-Suk Kim, Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Geumo-ro, 50612 Mulgeum-eup, Yangsan-si, Korea Tel: +82-55-360-1870 Fax: +82-55-360-1880 E-mail: iskim0710@gmail.com
Received 2015 December 16; Revised 2016 October 5; Accepted 2016 October 20.

Abstract

Background

Detection of antibodies to extractable nuclear antigens (ENAs) is needed for the diagnosis in systemic autoimmune diseases. In this study, we compared three reagents using line immunoblot assay (LIA) or multiplex bead immunoassay for detecting the anti-ENAs.

Methods

A total of 89 sera were tested by 3 different assays: EUROASSAY Anti-ENA Profile (Euroimmune, Germany), Polycheck Autoimmune Test (Biocheck GmbH, Germany), and FIDIS™ Connective Profile (Biomedical Diagnostics, France). The following individual ENAs were investigated: Sm, SS-A (Ro), SS-B (La), Scl-70, Jo-1 and RNP. We reviewed medical records to investigate the discrepant results among three methods.

Results

Overall percent agreements were 96.1% between EUROASSAY Anti-ENA Profile and FIDIS™ Connective profile; 90.4% between EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test using the manufacturers’ cutoff; 96.4% between EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test using a upward cutoff; 90.4% between FIDIS™ Connective profile and Polycheck Autoimmune Test the manufacturers’ cutoff; and 96.4% between FIDIS™ Connective profile and Polycheck Autoimmune Test a upward cutoff.

Conclusions

The three assays showed excellent agreement with each other. With appropriate cutoff, the all three assays for six of the anti-ENA tests investigated in this study can be used in clinical laboratories for detecting the anti-ENAs.

Keywords: Anti-extractable nuclear antigen antibodies; Antinuclear antibodies; Autoimmunity

Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test (N = 89)

Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and FIDIS Connective Profile (N = 89)

Comparison of the results for antibodies to extractable nuclear antigens by Polycheck Autoimmune Test FIDIS Connective Profile (N = 89)

Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and FIDIS Connective profile in the systemic autoimmune disorder (n = 33).

References

1. The Korean Society for Laboratory Medicine. Laboratory Medicine. 5 ed 2014.
2. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71–81.
3. Bossuyt X, Luyckx A. Antibodies to extractable nuclear antigens in antinuclear antibody–negative samples. Clin Chem 2005;51:2426–7.
4. Hoffman IE, Peene I, Veys EM, De Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clinical chem 2002;48:2171–6.
5. López-Longo FJ, Rodríguez-Mahou M, Escalona-Monge M, González CM, Monteagudo I, Carreño-Pérez L. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system. Lupus 2003;12:623–9.
6. Delpech A, Gilbert D, Daliphard S, Le Loet X, Godin M, Tron F. Antibodies to Sm, RNP and SSB detected by solid–phase ELISAs using recombinant antigens: A comparison study with counter immunoelectrophoresis and immunoblotting. J Clin Lab Anal 1993;7:197–202.
7. Martins TB, Burlingame R, von Mühlen CA, Jaskowski TD, Litwin CM, Hill HR. Evaluation of multiplexed fluorescent microsphere immuno- assay for detection of autoantibodies to nuclear antigens. Clin Diagn Lab Immunol 2004;11:1054–9.
8. Kim JM, Ihm CH, Sin DH, Ihm MK, Sim SC. Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases. Korean J Lab Med 2008;28:353–61.
9. Rouquette AM, Desgruelles C, Laroche P. Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol 2003;120:676–81.
10. Rouquette AM, Desgruelles C. Detection of antibodies to dsDNA: an overview of laboratory assays. Lupus 2006;15:403–7.
11. Johnson S, Goek O, Singh-Grewal D, Vlad S, Feldman B, Felson D, et al. Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum 2007;57:1119–33.
12. Altman DG. Practical statistics for medical research: CRC press 1990.
13. James K, Meek G. Evaluation of commercial enzyme immunoassays compared to immunofluorescence and double diffusion for autoantibodies associated with autoimmune diseases. Am J Clin Pathol 1992;97:559–65.
14. Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann N Y Acad Sci 2005;1050:340–7.
15. Vercammen M, Meirlaen P, Sennesael J, Velkeniers B, T'Kint S, Verbruggen L, et al. Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Clin Chem Lab Med 2007;45:505–12.

Article information Continued

Copyright © 2018 Kosin University School of Medicine Proceedings

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table 1.

Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and Polycheck Autoimmune Test (N = 89)

Cutoff of Polycheck Autoimmune Test = grade 1
Antigen Concordant results Discrepant results Concordance rate (%) Kappa coefficient (95% CI) P-value
EUROASSAY-/ Polycheck- EUROASSAY+/ Polycheck+ EUROASSAY-/ Polycheck+ EUROASSAY+/ Polycheck-
Sm 74 1 14 0 84.3 0.11 (-0.32-0.53) 0.027
SSA 57 22 8 2 88.8 0.74 (0.58-0.89) 0.000
SSB 67 5 17 0 80.9 0.31 (0.01-0.60) 0.000
scl-70 80 4 5 0 94.4 0.59 (0.24-0.94) 0.000
Jo-1 86 0 2 1 96.6 N/A N/A
nRNP 83 2 0 4 95.5 0.48 (-0.01-0.98) 0.000
Cutoff of Polycheck Autoimmune Test = grade 2
Antigen Concordant results Discrepant results Concordance rate (%) Kappa coefficient (95% CI) P-value
EUROASSAY-/ Polycheck- EUROASSAY+/ Polycheck+ EUROASSAY-/ Polycheck+ EUROASSAY+/ Polycheck-
Sm 85 1 3 0 96.6 0.39 (-0.29-1.07) 0.000
SSA 64 21 1 3 95.5 0.88 (0.77-0.99) 0.000
SSB 77 4 7 1 91.0 0.46 (0.10-0.82) 0.000
scl-70 84 4 1 0 98.9 0.88 (0.66-1.11) 0.000
Jo-1 88 0 0 1 98.9 N/A N/A
nRNP 83 2 0 4 95.5 0.48 (-0.01-0.98) 0.000

Abbreviations: CI, confidence interval; N/A, did not calculated; RNP, ribonucleic protein; Scl-70, scleroderma 70.

Table 2.

Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and FIDIS Connective Profile (N = 89)

Antigen Concordant results Discrepant results Concordance rate (%) Kappa coefficient (95% CI) P-value
EUROASSAY-/ FIDIS EUROASSAY+/ FIDIS+ EUROASSAY-/ FIDIS+ EUROASSAY+/ FIDIS-
Sm 85 1 0 3 96.6 0.39 (-0.29-1.07) 0.000
SSA 61 19 6 3 89.9 0.74 (0.58-0.90) 0.000
SSB 80 5 4 0 95.5 0.69 (0.40-0.99) 0.000
scl-70 84 4 1 0 98.9 0.88 (0.66-1.11) 0.000
Jo-1 88 0 0 1 98.9 N/A N/A
RNP 83 3 0 3 96.6 0.65 (0.26-1.04) 0.000

Abbreviations: CI, confidence interval; N/A, did not calculated; RNP, ribonucleic protein; Scl-70, scleroderma 70.

Table 3.

Comparison of the results for antibodies to extractable nuclear antigens by Polycheck Autoimmune Test FIDIS Connective Profile (N = 89)

Cutoff of Polycheck Autoimmune Test = grade 1
Antigen Concordant results Discrepant results Concordance rate (%) Kappa coefficient (95% CI) P-value
Polycheck-/ FIDIS- Polycheck+/ FIDIS+ Polycheck-/ FIDIS- Polycheck+/ FIDIS+
Sm 74 1 0 14 84.3 0.11 (-0.32-0.54) 0.026
SSA 57 19 2 11 85.4 0.65 (0.47-0.82) 0.000
SSB 66 8 1 14 83.1 0.44 (0.17-0.70) 0.000
scl-70 79 4 1 5 93.3 0.54 (0.18-0.90) 0.000
Jo-1 87 0 0 2 97.8 N/A N/A
nRNP 86 2 1 0 98.9 0.79 (0.40-1.20) 0.000
Cutoff of Polycheck Autoimmune Test = grade 2
Antigen Concordant results Discrepant results Concordance rate (%) Kappa coefficient (95% CI) P-value
Polycheck-/ FIDIS- Polycheck+/ FIDIS+ Polycheck-/ FIDIS- Polycheck+/ FIDIS+
Sm 85 1 3 0 96.6 0.39 (-0.29-1.07) 0.000
SSA 64 21 1 3 92.1 0.79 (0.63-0.94) 0.000
SSB 77 4 7 1 93.3 0.66 (0.40-0.92) 0.000
scl-70 84 4 1 0 97.8 0.79 (0.50-1.08) 0.000
Jo-1 88 0 0 1 100.0 N/A N/A
nRNP 83 2 0 4 98.9 0.79 (0.39-1.20) 0.000

Abbreviations: CI, confidence interval; N/A, did not calculated; RNP, ribonucleic protein; Scl-70, scleroderma 70.

Table 4.

Comparison of the results for antibodies to extractable nuclear antigens by EUROASSAY Anti-ENA Profile and FIDIS Connective profile in the systemic autoimmune disorder (n = 33).

Antigen Concordant results Discrepant results Concordance rate (%) Kappa coefficient (95% CI) P-value
EUROASSAY-/ FIDIS EUROASSAY+/ FIDIS+ EUROASSAY-/ FIDIS+ EUROASSAY+/ FIDIS-
Sm 32 1 0 0 100.0 1.00 (1.00-1.00) 0.000
SSA 16 15 0 2 93.9 0.88 (0.72-1.04) 0.000
SSB 27 4 2 0 93.9 0.77 (0.45-1.08) 0.000
scl-70 30 3 0 0 100.0 1.00 (1.00-1.00) 0.000
Jo-1 33 0 0 0 100.0 N/A N/A
RNP 29 2 0 2 93.9 0.64 (0.15-1.12) 0.000

Abbreviations: SLE, systemic lupus erythematosus; CI, confidence interval; N/A, did not calculated; RNP, ribonucleic protein; Scl-70, scleroderma 70.